Home / Generics

Generics

News

EMA recommends approval for two new generics posted 06/12/2019

The European Medicines Agency’s (EMA) human medicines committee recommended seven new medicines for approval at its November...

Dubai’s LIFEPharma signs historic agreement with Canada’s Apotex posted 22/11/2019

LIFEPharma, a wholly-owned subsidiary of the United Arab Emirates (UAE)-headquartered VPS Healthcare, has announced a histori...

Glenmark and Lupin gain FDA approval for nervous system agents posted 12/11/2019

Indian generics maker Glenmark Pharmaceuticals has been granted tentative US Food and Drug Administration (FDA) approval for...

AB004665 Alimta and Orfadin generics approved by FDA posted 15/10/2019

The US Food and Drug Administration (FDA) has tentatively approved Mylan’s pemetrexed, a generic version of Eli Lilly’s cance...

AB004665 EMA approves leukaemia and multiple myeloma generics posted 05/10/2019

The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) announced on 20 September 2019 th...

 

Research

FDA generics approvals increasing but not for at-risk generics posted 12/12/2019

Analysis of generics approvals by the US Food and Drug Administration (FDA) reveals a slight increase in the total number of...

Safety of generics in US questioned posted 12/12/2019

US Food and Drug Administration (FDA) regulations guarantee a safe drug supply. However, author Michael White, from the Healt...

Generics transition brings economic benefits to Canada posted 12/12/2019

Economic analysis of genericization of cancer medicines in Canada has confirmed their cost-effectiveness. This rare example o...

A call for economic reassessment of drug regimens posted 12/12/2019

Canadian researchers have called for the cost-effectiveness of drug products to be routinely reassessed. Their study, publish...

Pharmacy chain drives choice among US generics manufacturers posted 25/10/2019

A recent study shows that the dispensing pharmacy chain is a strong driver of generics manufacturer choice in the US, which c...

 

General

WHO prequalifies antiparasitic API posted 06/12/2019

The World Health Organization (WHO) has announced the prequalification of Pyrimethamine, manufactured by Macleods Pharmaceuti...

FDA identifies causes of drug shortages, recommends solutions posted 22/11/2019

In response to growing concern over drug shortages, the US Food and Drug Administration (FDA) has released a report and accom...

16704526_l UK Labour Party proposes state run generics manufacturer posted 25/10/2019

In a speech at the 2019 Labour Party Conference, leader Jeremy Corbyn introduced the ‘Medicines For The Many’ initiative, whi...

Ranitidine recalls escalate as FDA declares ‘unacceptable’ levels of NDMA in the drug posted 23/10/2019

On 2 October 2019, the US Food and Drug Administration (FDA) declared that it had found ‘unacceptable’ levels of the probable...

Carcinogen contamination halts distribution of generic Zantac posted 07/10/2019

Heartburn drug Zantac (ranitidine) is being taken off markets worldwide following findings that the medications may be contam...

Generics News Research General

more

Biosimilars News Research General

more